Heterogeneity in pre-vaccination population immunity can contribute to variability in vaccine effectiveness estimates
Pillai, A. N.; Park, S. W.; Lipsitch, M.; Cowling, B. J.; Cobey, S.
Show abstract
Vaccine effectiveness (VE) estimates can vary widely between years and populations, even for the same vaccine. Estimated VE is known to be sensitive to susceptible depletion and differences in pre-vaccination infection risk between vaccinated and unvaccinated populations. However, how variation in pre-vaccination risk within and between the two groups affects VE estimates over time remains unclear. This uncertainty is especially important given negative VE estimates. We investigated the difference between estimated VE and true vaccine protection considering continuous distributions of pre-vaccination infection risk under three scenarios. When the vaccinated and unvaccinated populations differ in their mean risk, estimated VE can be higher or lower than true vaccine protection. Similar patterns arise when both populations share identical means but different risk distributions. Finally, if infection-derived immunity lasts longer than vaccine protection, annual VE estimates can vary by tens of percentage points between years despite constant true vaccine protection. These theoretical results underscore that VE studies estimate contrasting risk between vaccinated and unvaccinated individuals in a particular time and place, and VE estimates can vary counterintuitively between years and populations even with constant vaccine-induced protection. Explaining variability in estimated VE thus requires a more complete understanding of populations' distributions of infection risk.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 95%
- Interpreting vaccine efficacy trial results for infection and transmission 94%
- Cost-effectiveness of routine COVID-19 adult vaccination programmes in England 93%
Similar papers in this journal
- Statistical Methods for Estimating the Protective Effects of Immune Markers Using Test-Negative Designs 95%
- Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel 93%
- Misclassification of yellow fever vaccination status revealed through hierarchical Bayesian modeling 92%
Similar papers in this journal
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 94%
- Importance of epidemic severity and vaccine mode of action and availability for delaying the second vaccine dose 94%
- Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilities 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.